A VIM metallo-␤-lactamase-producing Aeromonas hydrophila strain carrying an integron-borne bla VIM-4 gene was isolated from a cirrhotic patient's fecal sample in a Budapest hospital. The variable region of this integron is identical with that of a previously characterized integron from Pseudomonas aeruginosa clinical isolates in Pécs in southern Hungary.
ceftazidime, cefepime, cefotaxime, cefoxitin, cefoperazone, piperacillin, and piperacillin-tazobactam disks with or without 750 g EDTA. To prepare ␤-lactam-EDTA disks, 750 g EDTA in the form of a 0.5 M EDTA solution (pH 8.0) was added to a ␤-lactam disk placed on a Mueller-Hinton agar plate (3, 23) .
Detection of bla VIM genes and class 1 integrons by PCR and sequencing was performed as described earlier (13, 14) . Conjugation experiments were performed on Mueller-Hinton agar plates with the Escherichia coli J5-3 Rif r and Pseudomonas aeruginosa PAO4089Rp strains (12) as recipients. Transconjugants were selected on Mueller-Hinton agar plates containing 300 and 100 g/ml rifampin, respectively, and 32 g/ml cefotaxime or 128 g/ml ticarcillin.
The A. hydrophila isolate MB443 was recovered in October 2005 from a fecal sample from a 68-year-old male patient suffering from alcoholic liver disease (cirrhosis) associated with pathological fluid accumulation within the abdominal cavity. According to the anamnesis recorded in the Budapest hospital, the clinical history of the patient included childhood hepatitis and later appendectomy but no relevant antibiotic treatment. After the drainage of the ascites fluid, the patient was released from the hospital and started on diuretic therapy. A. hydrophila was not isolated from any other sample types.
The antimicrobial susceptibility profile of isolate MB443 is shown in Table 1 together with the corresponding values de- termined for the control A. hydrophila strain ATCC 7966. While MB443 was resistant to ceftazidime, cefepime, piperacillin-tazobactam, and imipenem, it remained susceptible to aztreonam. This profile is often observed among acquired MBLproducing gram-negative clinical isolates (14) .
Although Aeromonas spp. possess a chromosomal MBL that hydrolyzes the carbapenems, wild-type strains are usually categorized under standardized in vitro testing conditions as carbapenem susceptible (20, 22) . Under selective pressure of certain antibiotics, the emergence of ␤-lactamase-overexpressing carbapenem-resistant Aeromonas species mutant strains has been observed (8, 10) . The MBL Etest does not detect the presence of the chromosomal MBLs in wild-type strains (22) . For isolate MB443 and for the control strain the MICs could not be determined by the MBL Etest as the inhibitory ellipse did not reach the calibrated scale on the strip (Fig. 1) . However, for isolate MB443, Ն10-mm increases of the inhibitory zones around all ␤-lactam disks tested after the addition of 750 g EDTA to the disks were observed (Table 2) . Moreover, a typical synergistic zone between the cefoxitin and cefoxitin-EDTA disks was detected (Fig. 2) . These observations indicated the presence of an acquired MBL with a much broader substrate profile than that of CphA.
PCR experiments detected a bla VIM-4 gene located on a class 1 integron. The variable region of this integron was sequenced, and it was found to be identical with that of an integron previously characterized from P. aeruginosa isolates in Pécs in southern Hungary, with GenBank accession number AY702100 (Fig. 3) (14) . This integron carries two resistance gene cassettes, an aacA4 gene in the first position followed by a bla VIM-4 gene cassette that contains a 170-bp duplication. To the best of our knowledge, this is the first example of a VIM MBL-producing isolate within the Aeromonas genus worldwide. Mating assays failed to transfer the bla VIM gene to the recipient E. coli and P. aeruginosa strains under the experimental conditions applied. This observation is similar to several previous reports of conjugation experiments with VIM-producing clinical isolates as donors (13, 14) .
The potential of Aeromonas species carrying antibiotic resistance genes to enter the food chain and subsequently infect or colonize humans deserves attention. Class 1 integrons that harbor trimethoprim-sulfamethoxazole, tetracycline, aminoglycoside, and chloramphenicol resistance determinants and also an IMP MBL were detected in Aeromonas spp. in previous studies (4, 5, 11, 17, 21) . In this report we identified an integron-borne bla VIM-4 gene from A. hydrophila, a previously un-FIG. 1. Etest MBL strip for the A. hydrophila isolate MB443. IP stands for imipenem concentrations (4 to 256 g/ml) and IPI for imipenem (1 to 64 g/ml) plus a constant level of EDTA. IP and IPI MICs should be read where the respective inhibition ellipses intersect the strip (AB Biodisk, Solna, Sweden). The origin of acquired MBLs of human pathogens is still unknown (18) . Aeromonas species isolates carrying such genes could provide a link between their supposed environmental pool and human-pathogenic bacteria. Based on our observations further molecular and metagenomic studies are needed to identify and characterize integron-containing bacteria from environmental sources that share the same ecological niches with the motile aeromonads.
Nucleotide sequence accession number. The nucleotide sequence for the bla VIM-4 allele has been submitted to GenBank under accession number EU581706.
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